Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

118.45 -0.36 (-0.30%)
Streaming Delayed Price Updated: 3:09 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,863,980
Open 118.40
Bid (Size) 118.44 (400)
Ask (Size) 118.71 (200)
Prev. Close 118.81
Today's Range 118.05 - 120.63
52wk Range 29.17 - 124.49
Shares Outstanding 106,313,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Mid-Cap Rotation: Fed Rate Cuts Spark a New Bull Run for the 'Forgotten' Middle Market
As the Federal Reserve transitions from its long-standing "higher-for-longer" stance to a deliberate cycle of monetary easing, the U.S. equity market is witnessing a profound shift in leadership. For... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B ↗
When asked about the company’s strategic transactions, CEO Mark Goldsmith said at a conference that the company has a policy of not commenting on rumors or speculation. 
Via Stocktwits

Performance

YTD
+49.9%
+49.9%
1 Month
+47.6%
+47.6%
3 Month
+121.7%
+121.7%
6 Month
+218.2%
+218.2%
1 Year
+189.5%
+189.5%

More News

Read More
News headline image
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Merck In Talks To Acquire Revolution Medicines For About $30B: Report ↗
Via Stocktwits
Merck Looks To Buy Cancer Drugmaker Revolution Medicines: Report ↗
Via Stocktwits
News headline image
Why Revolution Medicines Stock Surged by 11% Today ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight ↗
Via Benzinga
News headline image
Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
Via MarketMinute
Topics Intellectual Property
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Revolution Medicines Stock Soars On Report Of AbbVie Takeover ↗
Via Stocktwits
News headline image
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Small-Cap Renaissance: Why 2026 is the Year of the Russell 2000 and XSU
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Up Nearly 400% This Year, Can Oklo Stock Still Rise Higher? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? ↗
Via Benzinga
News headline image
Revolution Medicines (RVMD) Earnings Transcript ↗
Via The Motley Fool
News headline image
Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement ↗
Via Benzinga
News headline image
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗
Via Investor's Business Daily
News headline image
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗
Via Benzinga
Topics Economy
News headline image
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗
Via Benzinga
News headline image
'No Need To Sell' Martin Marietta Materials, Cramer Says: 'It's Just A Great Long-Term Hold' ↗
Via Benzinga

Frequently Asked Questions

Is Revolution Medicines, Inc. - Common Stock publicly traded?
Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.
What exchange does Revolution Medicines, Inc. - Common Stock trade on?
Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?
The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market
What is the current price of Revolution Medicines, Inc. - Common Stock?
The current price of Revolution Medicines, Inc. - Common Stock is 118.45
When was Revolution Medicines, Inc. - Common Stock last traded?
The last trade of Revolution Medicines, Inc. - Common Stock was at 01/23/26 03:09 PM ET
What is the market capitalization of Revolution Medicines, Inc. - Common Stock?
The market capitalization of Revolution Medicines, Inc. - Common Stock is 12.59B
How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?
Revolution Medicines, Inc. - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.